EMA — authorised 4 April 2018
- Marketing authorisation holder: PFIZER EUROPE MA EEIG
- Local brand name: Mylotarg
- Status: approved
EMA authorised Mylotarg on 4 April 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 4 April 2018; EMA has authorised it.
PFIZER EUROPE MA EEIG holds the EU marketing authorisation.